106 related articles for article (PubMed ID: 34906208)
1. Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial.
Stäuble CK; Lampert ML; Allemann S; Hatzinger M; Hersberger KE; Meyer Zu Schwabedissen HE; Imboden C; Mikoteit T
Trials; 2021 Dec; 22(1):919. PubMed ID: 34906208
[TBL] [Abstract][Full Text] [Related]
2. Clinical implementation of preemptive pharmacogenomics in psychiatry.
Skokou M; Karamperis K; Koufaki MI; Tsermpini EE; Pandi MT; Siamoglou S; Ferentinos P; Bartsakoulia M; Katsila T; Mitropoulou C; Patrinos GP;
EBioMedicine; 2024 Mar; 101():105009. PubMed ID: 38364700
[TBL] [Abstract][Full Text] [Related]
3. Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial.
Oslin DW; Chapman S; Duvall SL; Gelernter J; Ingram EP; Kranzler HR; Lehmann LS; Lynch JA; Lynch KG; Pyne JM; Shih MC; Stone A; Thase ME; Wray LO
Contemp Clin Trials; 2021 Feb; 101():106247. PubMed ID: 33316457
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study.
Ramsey CM; Lynch KG; Thase ME; Gelernter J; Kranzler HR; Pyne JM; Shih MC; Stone A; ; Oslin DW
J Affect Disord; 2021 Mar; 282():1272-1277. PubMed ID: 33601706
[TBL] [Abstract][Full Text] [Related]
5. Utilizing Pharmacogenomics Results to Guide Antidepressant Selection: A Case Report.
Vernacchia N; Toro-Pagán ND; Bardolia C; Amin NS
Sr Care Pharm; 2024 Apr; 39(4):143-150. PubMed ID: 38528337
[TBL] [Abstract][Full Text] [Related]
6. Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials.
Milosavljević F; Molden PE; Ingelman-Sundberg PM; Jukić APMM
Eur Neuropsychopharmacol; 2024 Apr; 81():43-52. PubMed ID: 38340605
[TBL] [Abstract][Full Text] [Related]
7. Effect of pharmacogenomic testing on the clinical treatment of patients with depressive disorder: A randomized clinical trial.
Xu L; Li L; Wang Q; Pan B; Zheng L; Lin Z
J Affect Disord; 2024 Aug; 359():117-124. PubMed ID: 38762035
[TBL] [Abstract][Full Text] [Related]
8. Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing
Varughese LA; Bhupathiraju M; Hoffecker G; Terek S; Harr M; Hakonarson H; Cambareri C; Marini J; Landgraf J; Chen J; Kanter G; Lau-Min KS; Massa RC; Damjanov N; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
Front Oncol; 2022; 12():859846. PubMed ID: 35865463
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.
Jeiziner C; Meyer Zu Schwabedissen HE; Hersberger KE; Allemann SS
Int J Clin Pharm; 2023 Dec; 45(6):1378-1386. PubMed ID: 37338707
[TBL] [Abstract][Full Text] [Related]
10. Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementation.
Conyers R; Halman A; Moore C; Stenta T; Felmingham B; Collier L; Khatri D; Spelman T; Williams E; Dyas R; Kotecha RS; Jessop S; Mateos MK; Swen J; Elliott DA
BMJ Open; 2024 May; 14(5):e085115. PubMed ID: 38760050
[TBL] [Abstract][Full Text] [Related]
11. Providers' Use of Pharmacogenetic Testing to Inform Antidepressant Prescribing: Results of Qualitative Interviews.
Vest BM; Wray LO; Thase ME; Brady LA; Chapman SR; Oslin DW
Psychiatr Serv; 2023 Dec; 74(12):1270-1276. PubMed ID: 37528698
[TBL] [Abstract][Full Text] [Related]
12. Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study].
Müller A; Konigorski S; Meißner C; Fadai T; Warren CV; Falkenberg I; Kircher T; Nestoriuc Y
BMC Psychiatry; 2023 Oct; 23(1):749. PubMed ID: 37833651
[TBL] [Abstract][Full Text] [Related]
13. Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
Lau-Min KS; Varughese LA; Nelson MN; Cambareri C; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
BMC Cancer; 2022 Jan; 22(1):47. PubMed ID: 34996412
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report.
Stäuble CK; Lampert ML; Mikoteit T; Hatzinger M; Hersberger KE; Meyer Zu Schwabedissen HE
Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357045
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic intervention improves treatment outcomes in Chinese adult men with schizophrenia.
Qin Y; Liu Y; Zhao J; Yang Y; Xiang H; Gao T; Huang C
J Psychiatr Res; 2024 Jun; 174():129-136. PubMed ID: 38631138
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service.
Rodríguez-Escudero I; Cedeño JA; Rodríguez-Nazario I; Reynaldo-Fernández G; Rodríguez-Vera L; Morales N; Jiménez-Vélez B; Ruaño G; Duconge J
J Am Coll Clin Pharm; 2020 Sep; 3(6):1028-1037. PubMed ID: 32964197
[TBL] [Abstract][Full Text] [Related]
17. Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study.
Cernat A; Samaan Z; Abelson J; Ramdyal A; Shaikh H; Vanstone M
J Community Genet; 2024 Jun; 15(3):293-309. PubMed ID: 38587601
[TBL] [Abstract][Full Text] [Related]
18. Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review.
Aboelbaha S; Zolezzi M; Elewa H
Neuropsychiatr Dis Treat; 2021; 17():2397-2419. PubMed ID: 34321882
[TBL] [Abstract][Full Text] [Related]
19. Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
Glewis S; Krishnasamy M; Lingaratnam S; Harris S; Underhill C; Georgiou C; Warren M; Campbell R; IJzerman M; Fagery M; Campbell I; Martin JH; Tie J; Alexander M; Michael M
Clin Transl Sci; 2023 Dec; 16(12):2700-2708. PubMed ID: 37877594
[TBL] [Abstract][Full Text] [Related]
20. A Canadian Simulation Model for Major Depressive Disorder: Study Protocol.
Ghanbarian S; Wong GWK; Bunka M; Edwards L; Cressman S; Conte T; Peterson S; Vijh R; Price M; Schuetz C; Erickson D; Riches L; Landry G; McGrail K; Austin J; Bryan S
Pharmacoecon Open; 2024 May; 8(3):493-505. PubMed ID: 38528312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
